PMID: 19149510Jan 20, 2009Paper

The gut and intestinal bacteria in chronic heart failure

Current Drug Metabolism
Anja SandekStephan von Haehling

Abstract

Chronic heart failure (CHF) is now recognized as a multisystem disorder with increased sympathetic tone, hormonal derangements, an anabolic/catabolic imbalance, endothelial dysfunction, and systemic low-grade inflammation affecting various organ systems. Pro-inflammatory cytokines appear to play important roles in that context. There is increasing evidence for the gut to have a pathophysiological role for both chronic inflammation and malnutrition in CHF. Indeed, disturbed intestinal microcirculation and barrier function in CHF seem to trigger cytokine generation, thereby contributing to further impairment in cardiac function. On the other hand, myocardial dysfunction can induce microcirculatory injuries leading to a disruption in the intestinal barrier. This amplifies the inflammatory response. Furthermore, alterations of specific absorption functions of the intestinal mucosa in CHF may aggravate symptoms of cachexia. The increased number of adherent bacteria seen in patients with CHF and elevated systemic levels of anti-lipopolysaccharide immunoglobulin A underscore this fact. Therefore, the gut poses an interesting target for therapeutic interventions in patients with CHF.

Associated Clinical Trials

Citations

Mar 20, 2010·World Journal of Gastroenterology : WJG·H Joe WangM Katherine Jung
Dec 7, 2013·World Journal of Gastroenterology : WJG·Maria-Angeles AllerVicente Lahera
Jul 19, 2013·European Heart Journal·Gerhard Rogler, Giuseppe Rosano
Apr 8, 2015·International Journal of Molecular Sciences·Yu-Jie ZhangHua-Bin Li
Jul 17, 2010·The Journal of Physiology·Eduard GuaschStanley Nattel
Jul 28, 2009·Heart Failure Clinics·Stephan von HaehlingStefan D Anker
Jun 28, 2012·European Journal of Heart Failure·Donah Zachariah, Paul R Kalra
Dec 16, 2010·European Journal of Clinical Investigation·Danny AlexanderAli J Marian
Sep 15, 2011·Biochimica Et Biophysica Acta·Melissa J PuppaJames A Carson
Oct 2, 2012·Nutrition·Miroslava ValentováAnja Sandek
Dec 3, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·L GentonJ Schrenzel
Dec 31, 2010·International Journal of Cardiology·Anja SandekMathias Rauchhaus
May 18, 2017·Journal of the American Heart Association·Akiomi YoshihisaYasuchika Takeishi
Jan 15, 2019·Current Opinion in Supportive and Palliative Care·Vincenzo B PolsinelliSanjiv J Shah
Jan 25, 2020·ESC Heart Failure·Cristiane C K MayerhoferMarius Trøseid
May 29, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Anja SandekStephan von Haehling
Jul 5, 2013·The American Journal of Clinical Nutrition·Prescilla V JeurinkLéon M J Knippels
Jul 16, 2019·Journal of Cachexia, Sarcopenia and Muscle·Raquel G F CostaMarília Seelaender
Oct 7, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yanbo YuGuofu Wang
Nov 11, 2019·Reviews in Endocrine & Metabolic Disorders·Maxime BranchereauChristophe Heymes
Apr 25, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Lin LiZhixi Hu
Mar 30, 2019·Heart Failure Reviews·Melanie RolfeJoshua Kramer
Jul 4, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Mark LueddeNorbert Frey
Oct 26, 2018·Journal of Cardiovascular Translational Research·Rosa M Agra-BermejoJosé R González-Juanatey
Sep 29, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Caitlin V Lewis, W Robert Taylor
Aug 26, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Yixin ZhangJie Du

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Current Opinion in Clinical Nutrition and Metabolic Care
Anja SandekStephan von Haehling
Journal of the American College of Cardiology
Anja SandekStefan D Anker
Pharmacology & Therapeutics
Stephan von HaehlingStefan D Anker
The American Journal of Cardiology
Stefan D AnkerAndrew J S Coats
© 2021 Meta ULC. All rights reserved